Trelegy Ellipta

Medicinal product

(Invented) name

Trelegy Ellipta

Active substance (s)

Flutikazono furoatas/Umeklidinas/Vilanterolas

Strength

92 µg/55 µg/22 µg

Pharmaceutical form

dozuoti įkvepiamieji milteliai

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

R03AL08, Vilanterol, umeclidinium bromide and fluticasone furoate

Marketing authorisation holder

GlaxoSmithKline Trading Services Limited, Airija

Date of authorisation

2017-11-10

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

10b

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Inhalation powder, pre-dispensed	1 dozėje
Flutikazono furoatas	92 µg
Umeklidinas	55 µg
Vilanterolas	22 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To
98375	84477	1084477	inhaliatorius	14 dozių N1	Receptinis	EU/1/17/1236/001	Netiekiama	-	-	No	-	-
98376	84478	1084478	inhaliatorius	30 dozių N1	Receptinis	EU/1/17/1236/002	Tiekiama	-	-	No	-	-
98377	84479	1084479	inhaliatorius	30 dozių N3 (90 dozių, sudėtinė)	Receptinis	EU/1/17/1236/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-11-10	Registruotas